Comparative in vitro activities of pristinamycin and other antimicrobial agents against genital pathogens.
The MICs of pristinamycin for genital pathogens were compared with those of ampicillin, tetracycline, erythromycin, and ciprofloxacin. Pristinamycin was active against all the strains studied. Because of this activity and its lack of toxicity, pristinamycin might be a valuable therapeutic agent for treating major sexually transmitted diseases.
Lefevre
J C
JC
Laboratoire Central de Microbiologie, Hôpital Purpan, Toulouse, France.
Bauriaud
R
R
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001419:Bacteria / Q000187:drug effects*; D006801:Humans; D008826:Microbial Sensitivity Tests; D010456:Peptides, Cyclic / Q000494:pharmacology; D012749:Sexually Transmitted Diseases / Q000382:microbiology*; D014769:Virginiamycin
D000900:Anti-Bacterial Agents; D010456:Peptides, Cyclic; D014769:Virginiamycin